Agree Titus,
I also like
HSV-2 program
•1 in 6 people in the US estimated to be HSV positive
•Significant market size
•Estimated growth north of $6Bn with treatment/vaccine available
•No approved vaccine available
HPV program
•Still many people not using or completing the HPV vaccine therefore need
•~<35% vaccination rate for HPV in the US
•Current HPV vaccines do not treat the disease (people already infected)
•Estimated at greater than $1Bn market potential for therapeutic vaccine
Ann: Investor Presentation , page-6
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.80 |
Change
-0.760(6.05%) |
Mkt cap ! $249.4M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.49 | $11.30 | $234.2K | 19.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4 | $11.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.90 | 251 | 1 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |